Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Mesoblast Ltd (MSB AU)
Watchlist
45
Analysis
Health Care
•
Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
06 Oct 2024 07:30
APAC Healthcare Weekly (Oct 6)-Strong Yen Impact, Sigma's Remedial Measures, Mesoblast's Fund Raise
BoJ interest rate hike leads to Yen appreciation, potentially impacting export-oriented healthcare industry. Sigma Healthcare addresses anti...
Tina Banerjee
Follow
352 Views
Share
bullish
•
Thematic (Sector/Industry)
•
16 Jul 2024 23:44
Australian Biotech Companies Amid Talk of Likely Interest Rate Cut
RBA keeps interest rates steady at 4.35%, while economists predict possible cut to 4.10% in 4Q24. Australian biotech companies should be in focus...
Tina Banerjee
Follow
289 Views
Share
bullish
•
Clinuvel Pharmaceuticals
•
07 Jul 2024 00:53
Clinuvel Pharmaceuticals (CUV AU): Positive Clinical Trial Result; Base Business Going Strong
Clinuvel Pharmaceuticals reported positive results from CUV151 study on DNA-repair capacity of afamelanotide. Expanding patient reach of Scenesse...
Tina Banerjee
Follow
410 Views
Share
bullish
•
Clinuvel Pharmaceuticals
•
06 May 2023 17:30
Clinuvel Pharmaceuticals (CUV AU): Portfolio Expansion Ensures Continued Profitable Growth
Clinuvel recorded double-digit revenue growth in H1FY23, backed by strong uptake of Scenesse. This year, the company launched its first...
Tina Banerjee
Follow
355 Views
Share
bullish
•
Quantitative Analysis
•
03 Apr 2023 05:47
Short Interest Movements (Q1 2023): HK, Korea, Taiwan, Australia
The Insight looks at movements in short interest across HK, Korea, Taiwan and Australia stocks over Q1 and highlights large increases/decreases in...
Brian Freitas
Follow
443 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x